Cystic Fibrosis Therapeutics Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Cystic Fibrosis Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cystic Fibrosis Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cystic Fibrosis Therapeutics Overall Market Size
2.1 Global Cystic Fibrosis Therapeutics Market Size: 2021 VS 2027
2.2 Global Cystic Fibrosis Therapeutics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cystic Fibrosis Therapeutics Players in Global Market
3.2 Top Global Cystic Fibrosis Therapeutics Companies Ranked by Revenue
3.3 Global Cystic Fibrosis Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Cystic Fibrosis Therapeutics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Cystic Fibrosis Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cystic Fibrosis Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Cystic Fibrosis Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Cystic Fibrosis Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cystic Fibrosis Therapeutics Market Size Markets, 2021 & 2027
4.1.2 CFTR
4.1.3 Mucolytics
4.1.4 PERT
4.1.5 Anti-infectives
4.1.6 Bronchodilators
4.2 By Type - Global Cystic Fibrosis Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Cystic Fibrosis Therapeutics Revenue, 2016-2021
4.2.2 By Type - Global Cystic Fibrosis Therapeutics Revenue, 2022-2027
4.2.3 By Type - Global Cystic Fibrosis Therapeutics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cystic Fibrosis Therapeutics Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.2 By Application - Global Cystic Fibrosis Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Cystic Fibrosis Therapeutics Revenue, 2016-2021
5.2.2 By Application - Global Cystic Fibrosis Therapeutics Revenue, 2022-2027
5.2.3 By Application - Global Cystic Fibrosis Therapeutics Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Cystic Fibrosis Therapeutics Market Size, 2021 & 2027
6.2 By Region - Global Cystic Fibrosis Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Cystic Fibrosis Therapeutics Revenue, 2016-2021
6.2.2 By Region - Global Cystic Fibrosis Therapeutics Revenue, 2022-2027
6.2.3 By Region - Global Cystic Fibrosis Therapeutics Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Cystic Fibrosis Therapeutics Revenue, 2016-2027
6.3.2 US Cystic Fibrosis Therapeutics Market Size, 2016-2027
6.3.3 Canada Cystic Fibrosis Therapeutics Market Size, 2016-2027
6.3.4 Mexico Cystic Fibrosis Therapeutics Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Cystic Fibrosis Therapeutics Revenue, 2016-2027
6.4.2 Germany Cystic Fibrosis Therapeutics Market Size, 2016-2027
6.4.3 France Cystic Fibrosis Therapeutics Market Size, 2016-2027
6.4.4 U.K. Cystic Fibrosis Therapeutics Market Size, 2016-2027
6.4.5 Italy Cystic Fibrosis Therapeutics Market Size, 2016-2027
6.4.6 Russia Cystic Fibrosis Therapeutics Market Size, 2016-2027
6.4.7 Nordic Countries Cystic Fibrosis Therapeutics Market Size, 2016-2027
6.4.8 Benelux Cystic Fibrosis Therapeutics Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Cystic Fibrosis Therapeutics Revenue, 2016-2027
6.5.2 China Cystic Fibrosis Therapeutics Market Size, 2016-2027
6.5.3 Japan Cystic Fibrosis Therapeutics Market Size, 2016-2027
6.5.4 South Korea Cystic Fibrosis Therapeutics Market Size, 2016-2027
6.5.5 Southeast Asia Cystic Fibrosis Therapeutics Market Size, 2016-2027
6.5.6 India Cystic Fibrosis Therapeutics Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Cystic Fibrosis Therapeutics Revenue, 2016-2027
6.6.2 Brazil Cystic Fibrosis Therapeutics Market Size, 2016-2027
6.6.3 Argentina Cystic Fibrosis Therapeutics Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cystic Fibrosis Therapeutics Revenue, 2016-2027
6.7.2 Turkey Cystic Fibrosis Therapeutics Market Size, 2016-2027
6.7.3 Israel Cystic Fibrosis Therapeutics Market Size, 2016-2027
6.7.4 Saudi Arabia Cystic Fibrosis Therapeutics Market Size, 2016-2027
6.7.5 UAE Cystic Fibrosis Therapeutics Market Size, 2016-2027
7 Players Profiles
7.1 Vertex Pharmaceuticals
7.1.1 Vertex Pharmaceuticals Corporate Summary
7.1.2 Vertex Pharmaceuticals Business Overview
7.1.3 Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Major Product Offerings
7.1.4 Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Revenue in Global (2016-2021)
7.1.5 Vertex Pharmaceuticals Key News
7.2 F. Hoffmann-La Roche
7.2.1 F. Hoffmann-La Roche Corporate Summary
7.2.2 F. Hoffmann-La Roche Business Overview
7.2.3 F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Major Product Offerings
7.2.4 F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Revenue in Global (2016-2021)
7.2.5 F. Hoffmann-La Roche Key News
7.3 AbbVie
7.3.1 AbbVie Corporate Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Cystic Fibrosis Therapeutics Major Product Offerings
7.3.4 AbbVie Cystic Fibrosis Therapeutics Revenue in Global (2016-2021)
7.3.5 AbbVie Key News
7.4 Gilead Sciences
7.4.1 Gilead Sciences Corporate Summary
7.4.2 Gilead Sciences Business Overview
7.4.3 Gilead Sciences Cystic Fibrosis Therapeutics Major Product Offerings
7.4.4 Gilead Sciences Cystic Fibrosis Therapeutics Revenue in Global (2016-2021)
7.4.5 Gilead Sciences Key News
7.5 Novartis
7.5.1 Novartis Corporate Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Cystic Fibrosis Therapeutics Major Product Offerings
7.5.4 Novartis Cystic Fibrosis Therapeutics Revenue in Global (2016-2021)
7.5.5 Novartis Key News
7.6 AstraZeneca
7.6.1 AstraZeneca Corporate Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Cystic Fibrosis Therapeutics Major Product Offerings
7.6.4 AstraZeneca Cystic Fibrosis Therapeutics Revenue in Global (2016-2021)
7.6.5 AstraZeneca Key News
7.7 Bayer
7.7.1 Bayer Corporate Summary
7.7.2 Bayer Business Overview
7.7.3 Bayer Cystic Fibrosis Therapeutics Major Product Offerings
7.4.4 Bayer Cystic Fibrosis Therapeutics Revenue in Global (2016-2021)
7.7.5 Bayer Key News
7.8 Celtaxsys
7.8.1 Celtaxsys Corporate Summary
7.8.2 Celtaxsys Business Overview
7.8.3 Celtaxsys Cystic Fibrosis Therapeutics Major Product Offerings
7.8.4 Celtaxsys Cystic Fibrosis Therapeutics Revenue in Global (2016-2021)
7.8.5 Celtaxsys Key News
7.9 Pharmaxis
7.9.1 Pharmaxis Corporate Summary
7.9.2 Pharmaxis Business Overview
7.9.3 Pharmaxis Cystic Fibrosis Therapeutics Major Product Offerings
7.9.4 Pharmaxis Cystic Fibrosis Therapeutics Revenue in Global (2016-2021)
7.9.5 Pharmaxis Key News
7.10 ProQR Therapeutics
7.10.1 ProQR Therapeutics Corporate Summary
7.10.2 ProQR Therapeutics Business Overview
7.10.3 ProQR Therapeutics Cystic Fibrosis Therapeutics Major Product Offerings
7.10.4 ProQR Therapeutics Cystic Fibrosis Therapeutics Revenue in Global (2016-2021)
7.10.5 ProQR Therapeutics Key News
7.11 PTC Therapeutics
7.11.1 PTC Therapeutics Corporate Summary
7.11.2 PTC Therapeutics Business Overview
7.11.3 PTC Therapeutics Cystic Fibrosis Therapeutics Major Product Offerings
7.11.4 PTC Therapeutics Cystic Fibrosis Therapeutics Revenue in Global (2016-2021)
7.11.5 PTC Therapeutics Key News
7.12 Alcresta Therapeutics
7.12.1 Alcresta Therapeutics Corporate Summary
7.12.2 Alcresta Therapeutics Business Overview
7.12.3 Alcresta Therapeutics Cystic Fibrosis Therapeutics Major Product Offerings
7.12.4 Alcresta Therapeutics Cystic Fibrosis Therapeutics Revenue in Global (2016-2021)
7.12.5 Alcresta Therapeutics Key News
7.13 Insmed Incorporated
7.13.1 Insmed Incorporated Corporate Summary
7.13.2 Insmed Incorporated Business Overview
7.13.3 Insmed Incorporated Cystic Fibrosis Therapeutics Major Product Offerings
7.13.4 Insmed Incorporated Cystic Fibrosis Therapeutics Revenue in Global (2016-2021)
7.13.5 Insmed Incorporated Key News
7.14 Savara
7.14.1 Savara Corporate Summary
7.14.2 Savara Business Overview
7.14.3 Savara Cystic Fibrosis Therapeutics Major Product Offerings
7.14.4 Savara Cystic Fibrosis Therapeutics Revenue in Global (2016-2021)
7.14.5 Savara Key News
7.15 Cyclacel Pharmaceuticals
7.15.1 Cyclacel Pharmaceuticals Corporate Summary
7.15.2 Cyclacel Pharmaceuticals Business Overview
7.15.3 Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Major Product Offerings
7.15.4 Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Revenue in Global (2016-2021)
7.15.5 Cyclacel Pharmaceuticals Key News
7.16 Vectura
7.16.1 Vectura Corporate Summary
7.16.2 Vectura Business Overview
7.16.3 Vectura Cystic Fibrosis Therapeutics Major Product Offerings
7.16.4 Vectura Cystic Fibrosis Therapeutics Revenue in Global (2016-2021)
7.16.5 Vectura Key News
7.17 Allergan
7.17.1 Allergan Corporate Summary
7.17.2 Allergan Business Overview
7.17.3 Allergan Cystic Fibrosis Therapeutics Major Product Offerings
7.17.4 Allergan Cystic Fibrosis Therapeutics Revenue in Global (2016-2021)
7.17.5 Allergan Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer


List of Tables
Table 1. Cystic Fibrosis Therapeutics Market Opportunities & Trends in Global Market
Table 2. Cystic Fibrosis Therapeutics Market Drivers in Global Market
Table 3. Cystic Fibrosis Therapeutics Market Restraints in Global Market
Table 4. Key Players of Cystic Fibrosis Therapeutics in Global Market
Table 5. Top Cystic Fibrosis Therapeutics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Cystic Fibrosis Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Cystic Fibrosis Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Cystic Fibrosis Therapeutics Product Type
Table 9. List of Global Tier 1 Cystic Fibrosis Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cystic Fibrosis Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Vertex Pharmaceuticals
F. Hoffmann-La Roche
AbbVie
Gilead Sciences
Novartis
AstraZeneca
Bayer
Celtaxsys
Pharmaxis
ProQR Therapeutics
PTC Therapeutics
Alcresta Therapeutics
Insmed Incorporated
Savara
Cyclacel Pharmaceuticals
Vectura
Allergan